Bayer AG
XETRA:BAYN
Bayer AG
Short-Term Investments
Bayer AG
Short-Term Investments Peer Comparison
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Short-Term Investments
€4.8B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
33%
|
CAGR 10-Years
20%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Short-Term Investments
$134.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Short-Term Investments
€499m
|
CAGR 3-Years
59%
|
CAGR 5-Years
77%
|
CAGR 10-Years
-15%
|
|
MPH Health Care AG
XETRA:93M1
|
Short-Term Investments
€2.6m
|
CAGR 3-Years
104%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Short-Term Investments
€3.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Short-Term Investments
€1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Short-Term Investments?
Short-Term Investments
4.8B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Short-Term Investments amounts to 4.8B EUR.
What is Bayer AG's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
20%
Over the last year, the Short-Term Investments growth was -7%. The average annual Short-Term Investments growth rates for Bayer AG have been -15% over the past three years , 33% over the past five years , and 20% over the past ten years .